Skip to main content

Baker Bros. Advisors LP

SEC CIK
0001263508
Latest filing
Aug 14, 2026

RYTM holding history

Rhythm Pharmaceuticals, Inc. in every 13F filed by Baker Bros. Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RYTM overviewAll 13F holders of RYTMFull Q2 2026 holdings

Shares (Q2 2026)
5,604,483
Value
$622.3M
% of portfolio
3.1%
Quarters held
22
Since Q1 2021
Holdings of RYTM by Baker Bros. Advisors LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20265,604,483$622.3M3.1%00.0%UnchangedHolders
Q1 20265,604,483$487.4M2.8%00.0%UnchangedHolders
Q4 20255,604,483$599.9M3.5%00.0%UnchangedHolders
Q3 20255,604,483$566.0M4.1%00.0%UnchangedHolders
Q2 20255,604,483$354.1M3.4%00.0%UnchangedHolders
Q1 20255,604,483$296.9M3.3%−479,766−7.9%ReducedHolders
Q4 20246,084,249$340.6M3.6%−314,117−4.9%ReducedHolders
Q3 20246,398,366$335.2M3.5%+10.0%AddedHolders
Q2 20246,398,365$262.7M3.4%00.0%UnchangedHolders
Q1 20246,398,365$277.2M3.5%00.0%UnchangedHolders
Q4 20236,398,365$294.1M3.3%−303,984−4.5%ReducedHolders
Q3 20236,702,349$153.7M0.9%+204,082+3.1%AddedHolders
Q2 20236,498,267$107.2M0.6%00.0%UnchangedHolders
Q1 20236,498,267$115.9M0.6%+143,659+2.3%AddedHolders
Q4 20226,354,608$185.0M1.1%+291,906+4.8%AddedHolders
Q3 20226,062,702$148.5M1.0%+1,937,640+47.0%AddedHolders
Q2 20224,125,062$17.1M0.1%00.0%UnchangedHolders
Q1 20224,125,062$47.5M0.3%+261,823+6.8%AddedHolders
Q4 20213,863,239$38.6M0.2%00.0%UnchangedHolders
Q3 20213,863,239$50.5M0.2%00.0%UnchangedHolders
Q2 20213,863,239$75.6M0.3%+383,366+11.0%AddedHolders
Q1 20213,479,873$74.0M0.3%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.